Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

CI Financial Corp. ("CI" or the "Corporation") (TSX: CIX) today announced the commencement of the mailing of its management information circular and related shareholder meeting materials for the ...

House of Artisans, an initiative under The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) which is dedicated ...

New U.S. Senator Jim Justice has earned a reputation for dodging fines, ignoring court orders, breaking contracts, and paying ...

Tiger Global-backed Innovacer, healthcare-focused software-as-a-service startup (SaaS), has secured $275 million in a ...

Under the patronage of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, Abu Dhabi Sustainability Week ...

Elena Rybakina has confirmed her first post-Australian Open tournament as the world No. 6 will return to Abu Dhabi between ...

The deal counter is buzzing with new funding rounds across sectors. This and more in today’s ETtech Morning Dispatch.

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

U.S. law firm Skadden, Arps, Slate, Meagher & Flom on Thursday said it has opened an office in Abu Dhabi, following other ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class ...